ANVISA

ANVISA
Name	Agência Nacional de Vigilância Sanitária
Native name	Agência Nacional de Vigilância Sanitária
Abbreviation	ANVISA
Formation	26 January 1999
Headquarters	Brasília
Region served	Brazil
Leader title	Director-President
Parent organization	Ministério da Saúde

ANVISA is Brazil's federal sanitary regulatory body created to oversee health-related products and services across the Brazilian Federation. It was established to centralize regulatory functions formerly dispersed among agencies and to implement sanitary surveillance modeled on international counterparts. The agency's mandate intersects with public health administration in Brasília, legislative frameworks from Brasília's National Congress, and technical standards shaped by multilateral organizations.

History

ANVISA was founded following administrative reforms enacted by the National Congress and presidential decree in the late 1990s to modernize public administration in Brasília and strengthen regulatory institutions such as the Federal Revenue of Brazil and the Ministry of Health. Its creation paralleled reforms in other Latin American capitals and occurred amid policy debates involving the Supreme Federal Court and the Federal District. Early years featured institutional interactions with the National Health Surveillance System and implementation of laws passed by the Chamber of Deputies and the Federal Senate. Throughout the 2000s ANVISA engaged with judicial review from the Superior Court of Justice and administrative oversight by the Court of Auditors, while coordinating with state-level health secretariats and municipal health departments across São Paulo, Rio de Janeiro, Salvador, and other municipalities.

Organization and Governance

ANVISA's governance structure is anchored in a collegiate board and an executive director appointed by the Presidency of the Republic following nomination procedures involving Brasília's federal ministries. The agency works in coordination with the Ministry of Health, the National Health Council, the Federal Public Prosecutor's Office, and regulatory counterparts such as the Food and Drug Administration and the European Medicines Agency. Its internal divisions reflect technical units for pharmaceuticals, medical devices, cosmetics, food safety, and port and airport health control, with regional offices liaising with state and municipal health secretariats in São Paulo, Minas Gerais, Bahia, Paraná, and Rio Grande do Sul. Governance mechanisms include periodic audits by the Court of Auditors, oversight from the Chamber of Deputies, and judicial litigation within courts in Brasília and state capitals.

Regulatory Scope and Responsibilities

ANVISA's statutory responsibilities encompass sanitary surveillance of pharmaceuticals, biologicals, medical devices, food, cosmetics, tobacco products, and health services, interacting with laws enacted by the National Congress and administrative norms from the Ministry of Health. The agency issues registration and marketing authorizations, Good Manufacturing Practice inspections, post-market surveillance, and pharmacovigilance programs that coordinate with hospitals such as Hospital das Clínicas and clinics across São Paulo and Rio de Janeiro. It manages import and export controls at ports and airports including São Paulo–Guarulhos and Rio de Janeiro–Galeão, and implements sanitary measures referenced in global standards from the World Health Organization, the Pan American Health Organization, and the International Council for Harmonisation. ANVISA also enforces labeling and advertising regulations aligned with statutes considered by the Supreme Federal Court and implements countermeasures against counterfeit medicines in coordination with police forces and customs authorities.

Notable Policies and Decisions

Major policy decisions include approval and regulation frameworks for vaccines and biologics during public health emergencies that involved the National Immunization Program, collaborations with research institutions such as Fiocruz and Universidade de São Paulo, and expedited review procedures similar to those of the European Medicines Agency and the US Food and Drug Administration. ANVISA issued regulatory guidelines affecting tobacco control measures consistent with treaties ratified by the National Congress and implemented restrictions on advertising analogous to WHO Framework Convention on Tobacco Control measures. The agency adopted rules for biosimilar approvals, compassionate use pathways affecting patients at Hospital Sírio-Libanês, and limits on over-the-counter drug sales influenced by deliberations in Brasília's health policy arenas.

International Cooperation and Agreements

ANVISA maintains cooperation agreements and technical partnerships with the World Health Organization, the Pan American Health Organization, the European Medicines Agency, the US Food and Drug Administration, and regulatory networks such as the International Coalition of Medicines Regulatory Authorities. It engages in bilateral and multilateral initiatives with the Mercosur health ministries, the Organisation for Economic Co-operation and Development, and technical exchanges with national agencies in Argentina, Chile, Colombia, Mexico, and Portugal. The agency participates in global health diplomacy at United Nations forums and in specialized meetings convened by the World Trade Organization when sanitary and phytosanitary measures intersect with trade disputes adjudicated by trade panels.

Criticism and Controversies

ANVISA has faced criticism and legal challenges in courts in Brasília and state capitals regarding transparency of decision-making, timelines for market approvals, and perceived tensions between public health priorities and industry stakeholders including domestic and multinational pharmaceutical firms. Controversial episodes involved dispute over emergency authorizations, interactions with lobbying by industry associations, and scrutiny by auditors from the Court of Auditors and investigative journalism outlets in São Paulo and Rio de Janeiro. Judicial review by the Supreme Federal Court and litigation in administrative tribunals have addressed procedural issues and compliance with statutes passed by the National Congress.

Category:Brazilian government agencies Category:Health regulation